Management of operating theatre ambient temperature for major burn patients in a state-wide adult burns centre.

Introduction: The aim of this study was to investigate the efficacy of limiting increases in theatre ambient temperature to 27°C to prevent intraoperative patient hypothermia.

Methods: This single-centre, comparative cohort clinical study investigated the management of theatre ambient temperatures involving patients with ≥ 20 % TBSA burn injuries at Victorian Adult Burns Service (Melbourne, Australia). Data from the intervention group (August 2021 - February 2023, theatre ambient temperature increase limited to 27°C) was compared with a historical cohort (August 2019 - August 2021).

Harnessing Daily Routines for Early Detection of Cool Executive Delays: Validating the EFORTS Questionnaire.

: The early identification of executive function (EF) delays should involve parental reports on children's executive control in daily activities, capturing both "hot" and "cool" executive functions. This study aimed to revalidate the reliability and validity of the Executive Functions and Occupational Routines Scale (EFORTS) and examine whether it represents both hot and cool EFs : Parents of 971 children (469 boys) aged 3 to 11 years (M = 6.08, SD = 1.

How Single-Photon Switching Is Quenched with Multiple Λ-Level Atoms.

Single-photon nonlinearity, namely, the change in the response of the system as the result of the interaction with a single photon, is generally considered an inherent property of a single quantum emitter. Although the dependence on the number of emitters is well understood for the case of two-level systems, deterministic operations such as single-photon switching or photon-atom gates inherently require more complex level structures. Here, we theoretically consider single-photon switching in ensembles of emitters with a Λ-level scheme and show that the switching efficiency vanishes with the number of emitters.

Real-World Prescription Data for Intrathecal Drug Delivery: A Retrospective Analysis in 32,784 Patients.

Objectives: Currently, there are three monotherapy drugs approved by the United States Food and Drug Administration (FDA) for use in intrathecal drug delivery systems (IDDS): morphine, ziconotide, and baclofen. In practice, use includes alternate drugs, drug combinations, and drug concentrations. There is a paucity of real-world data examining prescription patterns for IDDS.